Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
11/2012
11/29/2012US20120302819 Treatment of cancer or tumors induced by the release of heat generated by various chains of magnetosomes extracted from magnetotactic bacteria and submitted to an alternative magnetic field
11/29/2012US20120302816 Therapeutic compositions and methods for targeted delivery of active agents
11/29/2012US20120302794 Derivatives of venlafaxine and methods of preparing and using the same
11/29/2012US20120302654 Hydrogels that undergo volumetric expansion in response to changes in their environment and their methods of manufacture and use
11/29/2012US20120302635 Water-Swellable Polymers
11/29/2012US20120302533 Derivatives of pyrimido [6,1-a] isoquinolin-4-one
11/29/2012US20120301720 Metal island coatings and method for synthesis
11/29/2012US20120301549 Complex formulation comprising aspirin coated with barrier containing hydrophobic additive, and hmg-coa reductase inhibitor
11/29/2012US20120301548 Oral complex composition comprising pseudoephedrine and levocetirizine
11/29/2012US20120301547 Paliperidone double-layered osmotic pump controlled release tablet and preparation method thereof
11/29/2012US20120301546 Acid-resistant soft gel compositions
11/29/2012US20120301545 Calcium carbonate granulation
11/29/2012US20120301544 Pharmaceutical formulations of loratadine for encapsulation and combinations thereof
11/29/2012US20120301543 Suppository comprising pantoprazole
11/29/2012US20120301542 Extended release formulations of rasagiline and uses thereof
11/29/2012US20120301541 Compressed core for pharmaceutical composition
11/29/2012US20120301540 Method of treatment for bladder dysfunction
11/29/2012US20120301539 Method of producing coated fine particles
11/29/2012US20120301538 Pharmaceutical compositions for the stimulation of stem cells
11/29/2012US20120301537 LIPOSOME CONTAINING shRNA MOLECULE TARGETING A THYMIDYLATE SYNTHASE AND USE THEREOF
11/29/2012US20120301535 Combination peptide-nanoparticles and delivery systems incorporating same
11/29/2012US20120301527 Hair follicle targeting compositions
11/29/2012US20120301520 Directly compressible magnesium hydroxide carbonate
11/29/2012US20120301519 Calcium carbonate granulation
11/29/2012US20120301518 Biocompatible and biodegradable elastomeric polymers
11/29/2012US20120301517 Two or more non-volatile solvent-containing compositions and methods for dermal delivery of drugs
11/29/2012US20120301516 Particle- containing complex porous materials
11/29/2012US20120301515 Anti-adhesion material
11/29/2012US20120301514 Development of bioactive electrospun coatings for biomedical applications
11/29/2012US20120301513 Composition comprising solanum glaucophyllum for preventing and/or treating hypocalcaemia and for stabilizing blood calcium levels
11/29/2012US20120301512 Tetrary Gene Delivery System for Gene Therapy and Methods of Its Use
11/29/2012US20120301511 Topical formulation comprising a corticosteroid as active ingredient
11/29/2012US20120301510 Tolerogenic synthetic nanocarriers coupled to cd1d-restricted antigens and methods of use
11/29/2012US20120301509 Boldline compounds for promoting bone growth
11/29/2012US20120301508 Compositions for Induction of Osteogenesis around an Implant
11/29/2012US20120301507 Method of tissue repair
11/29/2012US20120301397 Diagnosis of macrophage mediated disease
11/29/2012DE102011103394A1 Nanomolecular transport system useful for molecular oxygen and for preparing a drug for improving the transport of oxygen in blood and oxygen-carrying blood substitute, comprises a perfluoro compound in water-soluble colloid system
11/29/2012DE102011103270A1 Pulverförmige Mischung zur Herstellung von Levetiracetam-haltigen Tabletten Powdered mixture for the preparation of Levetiracetam tablets containing
11/29/2012CA2837174A1 Cb-183,315 compositions and related methods
11/29/2012CA2836891A1 Method for preparing microparticles with reduced initial burst and microparticles prepared thereby
11/29/2012CA2836865A1 Dry-coated tablet containing tegafur, gimeracil and oteracil potassium
11/29/2012CA2836847A1 Controlled release peptide formulations
11/29/2012CA2836831A1 Pharmaceutical composition
11/29/2012CA2836266A1 Delivery of coated hydrophobic active agent particles
11/29/2012CA2835912A1 Pharmaceutical composition comprising fexofenadine
11/29/2012CA2835716A1 Compositions for percutaneous administration of physiologically active agents
11/29/2012CA2835364A1 Pharmaceutical composition of rosuvastatin calcium
11/29/2012CA2834862A1 Pharmaceutical composition for administration to nails
11/29/2012CA2834855A1 Topical pharmaceutical composition based on semifluorinated alkanes
11/29/2012CA2834702A1 Systems and methods of stimulation and activation of fluids for use with instillation therapy
11/28/2012EP2527817A1 Skin substitute membrane, mold, and method of evaluating external preparation for skin
11/28/2012EP2527006A1 Quetiapine Formulation Having a Controlled-Release Coating
11/28/2012EP2526996A1 Intracutaneous injection
11/28/2012EP2526990A2 A dry powder for inhalation
11/28/2012EP2526963A1 Solution preparation containing stabilized antibody
11/28/2012EP2526956A1 A chinese medicine composition and preparation method and use thereof
11/28/2012EP2526943A1 Liquid formulation comprising an alpha-2 receptor agonist (e.g. clonidin) and oxybutynin (anti-muscarinic agent) for the treatment of sialorrhoea
11/28/2012EP2526940A2 Compositions containing enantiomeric equol, and methods for their making
11/28/2012EP2526932A1 Pharmaceutical composition
11/28/2012EP2526931A1 Wet granulation methods of cetyl myristate and/or cetyl palmitate
11/28/2012EP2526930A1 Vitamin formulation
11/28/2012EP2526929A1 Ophthalmic compositions containing a synergistic combination of two polymers
11/28/2012EP2526928A1 Increased Effectiveness of Allylamine Drug Compounds
11/28/2012EP2526927A1 Biocompatible nano- and microparticles coated with stabilisers for pulmonary application
11/28/2012EP2526926A1 Biocompatible nanopolymer particles with active agents for pulmonary application
11/28/2012EP2526925A1 A dose adjustable oral pump spray or aerosol spray containing memantine
11/28/2012EP2526924A1 A dose adjustable oral pump spray or aerosol spray containing rasagiline
11/28/2012EP2526923A1 Ophthalmic gel of gatifloxacin and preparation method thereof
11/28/2012EP2525835A2 Methods and compositions for nanoparticle-mediated cancer cell-targeted delivery
11/28/2012EP2525827A1 Pharmaceutical formulations of loratadine for encapsulation and combinations thereof
11/28/2012EP2525815A1 Irradiated biodegradable polymer microparticles
11/28/2012EP2525805A2 Oral care compositions and methods
11/28/2012EP2525802A2 A method of treating sinusitis, including chronic sinusitis
11/28/2012EP2525796A2 Aqueous solution comprising 3-quinuclidinones for the treatment of hyperproliferative, autoimmune and heart disease
11/28/2012EP2525793A2 Alpha-2 adrenergic agonist having long duration of intraocular pressure-lowering effect
11/28/2012EP2525789A1 Pharmaceutical formulations of naproxen for soft gel encapsulation and combinations thereof
11/28/2012EP2525788A2 Novel retigabine composition
11/28/2012EP2525787A2 Liquid formulations for long-acting g-csf conjugate
11/28/2012EP2525786A2 Pramipexole extended release tablets
11/28/2012EP2525785A1 Sustained release tablet formulation containing etodolac
11/28/2012EP2525784A1 Oral lyophilized compositions
11/28/2012EP2525783A1 Improved oral lysophilisates containing pvp/va
11/28/2012EP2525782A2 Formulations of nano-carriers and methods of preparing the same
11/28/2012EP2525781A1 Novel cationic lipids for oligonucleotide delivery
11/28/2012EP2525780A2 Synthetic nanostructures including nucleic acids and/or other entities
11/28/2012EP2525779A2 Liquid formulations for long-acting erythropoietin conjugate
11/28/2012EP2525778A2 Sustained-release nucleic acid matrix compositions
11/28/2012EP2525777A2 Material and method for treating internal cavities
11/28/2012EP2525776A2 Intracameral sustained release therapeutic agent implants
11/28/2012EP2525773A2 Easily appliable, storage stable, radiation-curable, pigmented, artificial nail gel coatings
11/28/2012EP2525660A1 Modified release formulation and methods of use
11/28/2012CN202554516U Externally used medicine bag for treating liver disease
11/28/2012CN202554515U Pediatric belly patch for relieving diarrhea
11/28/2012CN202554514U Calcium ion powder capsule
11/28/2012CN202554513U Physical antibacterial film for skin
11/28/2012CN202554512U Specially-pressed Chinese medicinal decoction piece or Chinese medicinal material
11/28/2012CN1988891B Coated tablet formulation and method
11/28/2012CN1943707B A Chinese traditional medicinal composition for anti-aging and its preparation method
11/28/2012CN102802729A Liquid dosage forms of isotretinoin
1 ... 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 ... 2991